Multiple Endocrine Neoplasia — Trials

Multiple Endocrine Neoplasia — Trials · CancerIndex

Clinical trials

Registered studies

68 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00947167	A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors	terminated	Phase 2	4	Pamela L. KunzOTHER	1	Mar 3, 2017	clinicaltrials

Data updated 22 days agoSource updated Mar 3, 2017source: clinicaltrials